How We Help

SHEPHERD is Filling the Rare Cancer Development Gap

SHEPHERD Therapeutics exists to develop therapeutics for rare cancers.
WE’VE ACCELERATED, STREAMLINED AND DIVERSIFIED THE PROCESS OF TURNING PROMISING RESEARCH INTO EFFECTIVE MEDICINE FOR RARE CANCER PATIENTS.

 

Our platform agnostic approach means that we develop the best molecule for an individual indication. And by putting AI and big data to work, we’re able to deploy and apply vast amounts of information across a broad range of cancers. Learn more about our development approach.

We aren’t just making drugs,
we’re building a platform to save lives